Market Executive Summary
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
Global mRNA Therapy market is projected to reach US$ 84450 million in 2029, increasing from US$ 36520 million in 2022, with the CAGR of 13.2% during the period of 2023 to 2029. Demand from mRNA Targeted Delivery in vivo and Genetically Modified T cells are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022.
The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.
Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global mRNA Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report:
By Company
Moderna
BioNTech
Pfizer
Arcturus Therapeutics Holdings Inc.
Astrazeneca
CureVac
Translate Bio
Regeneron Pharmaceuticals
Arcturus Therapeutics
Takeda Pharmaceutical Company
Novartis
Sanofi
Segment by Type
Vaccine
Drugs
Segment by Application
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the mRNA Therapy market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, mRNA Therapy introduction, etc. mRNA Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: Conclusions of mRNA Therapy market based on comprehensive survey.
Chapter 13: Methodology and Data Sources.
Table of Contents
1 Market Overview of mRNA Therapy
1.1 mRNA Therapy Market Overview
1.1.1 mRNA Therapy Product Scope
1.1.2 mRNA Therapy Market Status and Outlook
1.2 Global mRNA Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global mRNA Therapy Market Size by Region (2018-2029)
1.4 Global mRNA Therapy Historic Market Size by Region (2018-2023)
1.5 Global mRNA Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, mRNA Therapy Market Size (2018-2029)
1.6.1 North America mRNA Therapy Market Size (2018-2029)
1.6.2 Europe mRNA Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific mRNA Therapy Market Size (2018-2029)
1.6.4 Latin America mRNA Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa mRNA Therapy Market Size (2018-2029)
2 mRNA Therapy Market by Type
2.1 Introduction
2.1.1 Vaccine
2.1.2 Drugs
2.2 Global mRNA Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global mRNA Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global mRNA Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America mRNA Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe mRNA Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific mRNA Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America mRNA Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa mRNA Therapy Revenue Breakdown by Type (2018-2029)
3 mRNA Therapy Market Overview by Application
3.1 Introduction
3.1.1 mRNA Targeted Delivery in vivo
3.1.2 Genetically Modified T cells
3.1.3 Transforming Nanoparticles to Develop Immunotherapy for Cancer
3.1.4 Small Molecule Drugs Discovery
3.2 Global mRNA Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global mRNA Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global mRNA Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America mRNA Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe mRNA Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific mRNA Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America mRNA Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa mRNA Therapy Revenue Breakdown by Application (2018-2029)
4 mRNA Therapy Competition Analysis by Players
4.1 Global mRNA Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in mRNA Therapy as of 2022)
4.3 Date of Key Players Enter into mRNA Therapy Market
4.4 Global Top Players mRNA Therapy Headquarters and Area Served
4.5 Key Players mRNA Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 mRNA Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Moderna
5.1.1 Moderna Profile
5.1.2 Moderna Main Business
5.1.3 Moderna mRNA Therapy Products, Services and Solutions
5.1.4 Moderna mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Moderna Recent Developments
5.2 BioNTech
5.2.1 BioNTech Profile
5.2.2 BioNTech Main Business
5.2.3 BioNTech mRNA Therapy Products, Services and Solutions
5.2.4 BioNTech mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 BioNTech Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer mRNA Therapy Products, Services and Solutions
5.3.4 Pfizer mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Arcturus Therapeutics Holdings Inc. Recent Developments
5.4 Arcturus Therapeutics Holdings Inc.
5.4.1 Arcturus Therapeutics Holdings Inc. Profile
5.4.2 Arcturus Therapeutics Holdings Inc. Main Business
5.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Products, Services and Solutions
5.4.4 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Arcturus Therapeutics Holdings Inc. Recent Developments
5.5 Astrazeneca
5.5.1 Astrazeneca Profile
5.5.2 Astrazeneca Main Business
5.5.3 Astrazeneca mRNA Therapy Products, Services and Solutions
5.5.4 Astrazeneca mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Astrazeneca Recent Developments
5.6 CureVac
5.6.1 CureVac Profile
5.6.2 CureVac Main Business
5.6.3 CureVac mRNA Therapy Products, Services and Solutions
5.6.4 CureVac mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 CureVac Recent Developments
5.7 Translate Bio
5.7.1 Translate Bio Profile
5.7.2 Translate Bio Main Business
5.7.3 Translate Bio mRNA Therapy Products, Services and Solutions
5.7.4 Translate Bio mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Translate Bio Recent Developments
5.8 Regeneron Pharmaceuticals
5.8.1 Regeneron Pharmaceuticals Profile
5.8.2 Regeneron Pharmaceuticals Main Business
5.8.3 Regeneron Pharmaceuticals mRNA Therapy Products, Services and Solutions
5.8.4 Regeneron Pharmaceuticals mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Regeneron Pharmaceuticals Recent Developments
5.9 Arcturus Therapeutics
5.9.1 Arcturus Therapeutics Profile
5.9.2 Arcturus Therapeutics Main Business
5.9.3 Arcturus Therapeutics mRNA Therapy Products, Services and Solutions
5.9.4 Arcturus Therapeutics mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Arcturus Therapeutics Recent Developments
5.10 Takeda Pharmaceutical Company
5.10.1 Takeda Pharmaceutical Company Profile
5.10.2 Takeda Pharmaceutical Company Main Business
5.10.3 Takeda Pharmaceutical Company mRNA Therapy Products, Services and Solutions
5.10.4 Takeda Pharmaceutical Company mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Takeda Pharmaceutical Company Recent Developments
5.11 Novartis
5.11.1 Novartis Profile
5.11.2 Novartis Main Business
5.11.3 Novartis mRNA Therapy Products, Services and Solutions
5.11.4 Novartis mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Novartis Recent Developments
5.12 Sanofi
5.12.1 Sanofi Profile
5.12.2 Sanofi Main Business
5.12.3 Sanofi mRNA Therapy Products, Services and Solutions
5.12.4 Sanofi mRNA Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Sanofi Recent Developments
6 North America
6.1 North America mRNA Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe mRNA Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific mRNA Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America mRNA Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa mRNA Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 mRNA Therapy Market Dynamics
11.1 mRNA Therapy Industry Trends
11.2 mRNA Therapy Market Drivers
11.3 mRNA Therapy Market Challenges
11.4 mRNA Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Figures
List of Tables
Table 1. Global Market mRNA Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global mRNA Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global mRNA Therapy Market Size Share by Region (2018-2023)
Table 4. Global mRNA Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global mRNA Therapy Forecasted Market Size Share by Region (2024-2029)
Table 6. Global mRNA Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global mRNA Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global mRNA Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global mRNA Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global mRNA Therapy Revenue Market Share by Type (2024-2029)
Table 11. North America mRNA Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America mRNA Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe mRNA Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe mRNA Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific mRNA Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific mRNA Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America mRNA Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America mRNA Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa mRNA Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa mRNA Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global mRNA Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global mRNA Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global mRNA Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global mRNA Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global mRNA Therapy Revenue Market Share by Application (2024-2029)
Table 26. North America mRNA Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America mRNA Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe mRNA Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe mRNA Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific mRNA Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific mRNA Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America mRNA Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America mRNA Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa mRNA Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa mRNA Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global mRNA Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global mRNA Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in mRNA Therapy as of 2022)
Table 39. Date of Key Players Enter into mRNA Therapy Market
Table 40. Global mRNA Therapy Key Players Headquarters and Area Served
Table 41. mRNA Therapy Product Solution and Service
Table 42. Global mRNA Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Moderna Basic Information List
Table 45. Moderna Description and Business Overview
Table 46. Moderna mRNA Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in mRNA Therapy Business of Moderna (2018-2023)
Table 48. Moderna Recent Developments
Table 49. BioNTech Basic Information List
Table 50. BioNTech Description and Business Overview
Table 51. BioNTech mRNA Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in mRNA Therapy Business of BioNTech (2018-2023)
Table 53. BioNTech Recent Developments
Table 54. Pfizer Basic Information List
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer mRNA Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in mRNA Therapy Business of Pfizer (2018-2023)
Table 58. Pfizer Recent Developments
Table 59. Arcturus Therapeutics Holdings Inc. Basic Information List
Table 60. Arcturus Therapeutics Holdings Inc. Description and Business Overview
Table 61. Arcturus Therapeutics Holdings Inc. mRNA Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in mRNA Therapy Business of Arcturus Therapeutics Holdings Inc. (2018-2023)
Table 63. Arcturus Therapeutics Holdings Inc. Recent Developments
Table 64. Astrazeneca Basic Information List
Table 65. Astrazeneca Description and Business Overview
Table 66. Astrazeneca mRNA Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in mRNA Therapy Business of Astrazeneca (2018-2023)
Table 68. Astrazeneca Recent Developments
Table 69. CureVac Basic Information List
Table 70. CureVac Description and Business Overview
Table 71. CureVac mRNA Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in mRNA Therapy Business of CureVac (2018-2023)
Table 73. CureVac Recent Developments
Table 74. Translate Bio Basic Information List
Table 75. Translate Bio Description and Business Overview
Table 76. Translate Bio mRNA Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in mRNA Therapy Business of Translate Bio (2018-2023)
Table 78. Translate Bio Recent Developments
Table 79. Regeneron Pharmaceuticals Basic Information List
Table 80. Regeneron Pharmaceuticals Description and Business Overview
Table 81. Regeneron Pharmaceuticals mRNA Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in mRNA Therapy Business of Regeneron Pharmaceuticals (2018-2023)
Table 83. Regeneron Pharmaceuticals Recent Developments
Table 84. Arcturus Therapeutics Basic Information List
Table 85. Arcturus Therapeutics Description and Business Overview
Table 86. Arcturus Therapeutics mRNA Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in mRNA Therapy Business of Arcturus Therapeutics (2018-2023)
Table 88. Arcturus Therapeutics Recent Developments
Table 89. Takeda Pharmaceutical Company Basic Information List
Table 90. Takeda Pharmaceutical Company Description and Business Overview
Table 91. Takeda Pharmaceutical Company mRNA Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in mRNA Therapy Business of Takeda Pharmaceutical Company (2018-2023)
Table 93. Takeda Pharmaceutical Company Recent Developments
Table 94. Novartis Basic Information List
Table 95. Novartis Description and Business Overview
Table 96. Novartis mRNA Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in mRNA Therapy Business of Novartis (2018-2023)
Table 98. Novartis Recent Developments
Table 99. Sanofi Basic Information List
Table 100. Sanofi Description and Business Overview
Table 101. Sanofi mRNA Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in mRNA Therapy Business of Sanofi (2018-2023)
Table 103. Sanofi Recent Developments
Table 104. North America mRNA Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 105. North America mRNA Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 106. Europe mRNA Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 107. Europe mRNA Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 108. Asia-Pacific mRNA Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 109. Asia-Pacific mRNA Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 110. Asia-Pacific mRNA Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 111. Asia-Pacific mRNA Therapy Market Share by Region (2018-2023)
Table 112. Asia-Pacific mRNA Therapy Market Share by Region (2024-2029)
Table 113. Latin America mRNA Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 114. Latin America mRNA Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 115. Latin America mRNA Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 116. Middle East & Africa mRNA Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 117. Middle East & Africa mRNA Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 118. Middle East & Africa mRNA Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 119. mRNA Therapy Market Trends
Table 120. mRNA Therapy Market Drivers
Table 121. mRNA Therapy Market Challenges
Table 122. mRNA Therapy Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Therapy Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global mRNA Therapy Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global mRNA Therapy Market Share by Regions: 2022 VS 2029
Figure 4. Global mRNA Therapy Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America mRNA Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe mRNA Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific mRNA Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America mRNA Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa mRNA Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Vaccine
Figure 11. Global Vaccine Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Drugs
Figure 13. Global Drugs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global mRNA Therapy Market Size Share by Type: 2022 & 2029
Figure 15. North America mRNA Therapy Revenue Market Share by Type (2018-2029)
Figure 16. Europe mRNA Therapy Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific mRNA Therapy Revenue Market Share by Type (2018-2029)
Figure 18. Latin America mRNA Therapy Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa mRNA Therapy Revenue Market Share by Type (2018-2029)
Figure 20. mRNA Targeted Delivery in vivo Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Genetically Modified T cells Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Transforming Nanoparticles to Develop Immunotherapy for Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Small Molecule Drugs Discovery Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Global mRNA Therapy Market Size Share by Application: 2022 & 2029
Figure 25. North America mRNA Therapy Revenue Market Share by Application (2018-2029)
Figure 26. Europe mRNA Therapy Revenue Market Share by Application (2018-2029)
Figure 27. Asia-Pacific mRNA Therapy Revenue Market Share by Application (2018-2029)
Figure 28. Latin America mRNA Therapy Revenue Market Share by Application (2018-2029)
Figure 29. Middle East and Africa mRNA Therapy Revenue Market Share by Application (2018-2029)
Figure 30. mRNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players mRNA Therapy Market Share in 2022
Figure 32. North America mRNA Therapy Market Share by Country (2018-2029)
Figure 33. U.S. mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 34. Canada mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 35. Germany mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 36. France mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 37. U.K. mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 38. Italy mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 39. Russia mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 40. Nordic Countries mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 41. Asia-Pacific mRNA Therapy Market Share by Region (2018-2029)
Figure 42. China mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 43. Japan mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 44. South Korea mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 45. Southeast Asia mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 46. India mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 47. Australia mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 48. Latin America mRNA Therapy Market Share by Country (2018-2029)
Figure 49. Mexico mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 50. Brazil mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa mRNA Therapy Market Share by Country (2018-2029)
Figure 52. Turkey mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 54. UAE mRNA Therapy Market Size (2018-2029) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
